Healthcare provider profile · identity verified

Charles J Bettag, MD

Internal Medicine · MINOCQUA, WI · NPI 1881199750

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	881	295
Losartan Potassium	Losartan Potassium	607	193
Amlodipine Besylate	Amlodipine Besylate	541	184
Lisinopril	Lisinopril	470	153
Metoprolol Succinate	Metoprolol Succinate	440	140
Levothyroxine Sodium	Levothyroxine Sodium	370	111
Omeprazole	Omeprazole	338	124
Gabapentin	Gabapentin	298	92
Hydrochlorothiazide	Hydrochlorothiazide	295	91
Pantoprazole Sodium	Pantoprazole Sodium	276	89
Tamsulosin Hcl	Tamsulosin Hcl	269	93
Rosuvastatin Calcium	Rosuvastatin Calcium	251	88
Allopurinol	Allopurinol	243	78
Metformin Hcl	Metformin Hcl	218	75
Eliquis	Apixaban	205	57
Warfarin Sodium	Warfarin Sodium	190	58
Simvastatin	Simvastatin	167	59
Furosemide	Furosemide	157	56
Albuterol Sulfate Hfa	Albuterol Sulfate	154	75
Metoprolol Tartrate	Metoprolol Tartrate	142	45
Trazodone Hcl	Trazodone Hcl	133	45
Carvedilol	Carvedilol	124	38
Potassium Chloride	Potassium Chloride	124	49
Finasteride	Finasteride	103	29
Metformin Hcl Er	Metformin Hcl	102	39
Chlorthalidone	Chlorthalidone	96	36
Fluticasone Propionate	Fluticasone Propionate	96	44
Jardiance	Empagliflozin	91	33
Spironolactone	Spironolactone	90	37
Pravastatin Sodium	Pravastatin Sodium	86	26
Ezetimibe	Ezetimibe	78	24
Clopidogrel	Clopidogrel Bisulfate	76	29
Alendronate Sodium	Alendronate Sodium	73	24
Montelukast Sodium	Montelukast Sodium	72	31
Sertraline Hcl	Sertraline Hcl	72	29
Famotidine	Famotidine	70	31
Glipizide Er	Glipizide	70	23
Duloxetine Hcl	Duloxetine Hcl	65	24
Fluoxetine Hcl	Fluoxetine Hcl	64	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	61	19
Alprazolam	Alprazolam	60	18
Mirtazapine	Mirtazapine	58	19
Tramadol Hcl	Tramadol Hcl	58	23
Citalopram Hbr	Citalopram Hydrobromide	57	20
Escitalopram Oxalate	Escitalopram Oxalate	57	21
Ozempic	Semaglutide	57	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	19
Trulicity	Dulaglutide	56	13
Atenolol	Atenolol	54	18
Benazepril Hcl	Benazepril Hcl	53	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	20
Donepezil Hcl	Donepezil Hcl	50	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	16
Mounjaro	Tirzepatide	47	suppressed
Meloxicam	Meloxicam	46	12
Venlafaxine Hcl Er	Venlafaxine Hcl	46	16
Lovastatin	Lovastatin	45	12
Nitroglycerin	Nitroglycerin	45	36
Pregabalin	Pregabalin	45	20
Hydroxyzine Hcl	Hydroxyzine Hcl	44	20
Bupropion Xl	Bupropion Hcl	43	15
Buspirone Hcl	Buspirone Hcl	43	11
Amitriptyline Hcl	Amitriptyline Hcl	41	13
Irbesartan	Irbesartan	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	13
Prednisone	Prednisone	41	24
Paroxetine Hcl	Paroxetine Hcl	39	15
Doxazosin Mesylate	Doxazosin Mesylate	37	11
Xarelto	Rivaroxaban	37	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	12
Glimepiride	Glimepiride	35	11
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	12
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	11
Morphine Sulfate Er	Morphine Sulfate	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	19
Lorazepam	Lorazepam	31	28
Synthroid	Levothyroxine Sodium	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	22
Propranolol Hcl Er	Propranolol Hcl	30	14
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	28	suppressed
Ramipril	Ramipril	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Azithromycin	Azithromycin	22	12
Bumetanide	Bumetanide	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Amoxicillin	Amoxicillin	21	16
Enalapril Maleate	Enalapril Maleate	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Indomethacin	Indomethacin	18	suppressed
Naproxen	Naproxen	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Primidone	Primidone	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Valacyclovir	Valacyclovir Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Colchicine	Colchicine	14	suppressed
Glipizide	Glipizide	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Farxiga	Dapagliflozin Propanediol	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Indapamide	Indapamide	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error